脓毒症与急性呼吸衰竭患者ICU收治与结局的关联
该回顾性队列研究纳入美国27家医院2013至2018年高急性生理评分且急诊未需机械通气或血管活性药的脓毒症或急性呼吸衰竭患者,采用工具变量分位数回归分析ICU与病房收治的结局差异。脓毒症患者入ICU与更长住院时间和更高院内死亡率相关,而呼吸衰竭患者入ICU与更短住院时间和更低死亡率相关。
要点
- 脓毒症患者入ICU与住院时间延长1.32天及院内死亡率升高相关。
- 急性呼吸衰竭患者入ICU与住院时间缩短0.82天及院内死亡率降低相关。
- 脓毒症入ICU的危害集中于老年和合并症较少者,呼吸衰竭的获益集中于老年、高急性生理评分和合并症较多者。
核心结论
- 高急性生理评分脓毒症患者急诊未需生命支持时,首选病房收治与更短住院时间和更好生存相关。
- 急性呼吸衰竭患者入ICU分诊与改善生存相关。
研究设计与样本
- 2013至2018年美国两家医疗体系27家医院的回顾性队列研究。
- 采用两阶段工具变量分位数回归,以医院容量压力为工具变量。
- 纳入急诊未需机械通气或血管活性药、实验室急性生理评分v2≥100的脓毒症和/或急性呼吸衰竭患者。
主要发现
- 脓毒症患者(n=90,150)入ICU与住院时间延长1.32天(95%CI 1.01-1.63;P<0.001,死亡视为长住院时间)相关。
- 脓毒症患者入ICU与院内死亡率升高相关(OR 1.48;95%CI 1.13-1.88;P=0.004)。
- 呼吸衰竭患者(n=45,339)入ICU与住院时间缩短0.82天(95%CI -1.17至-0.46;P<0.001)相关。
- 呼吸衰竭患者入ICU与院内死亡率降低相关(OR 0.75;95%CI 0.57-0.96;P=0.04)。
- 呼吸衰竭住院时间敏感性分析(排除、忽略或删失死亡)结果不一致。
关键数值与推荐
- 脓毒症患者入ICU的院内死亡OR为1.48(95%CI 1.13-1.88;P=0.004)。
- 呼吸衰竭患者入ICU的院内死亡OR为0.75(95%CI 0.57-0.96;P=0.04)。
- 脓毒症患者入ICU住院时间延长1.32天(95%CI 1.01-1.63;P<0.001)。
- 呼吸衰竭患者入ICU住院时间缩短0.82天(95%CI -1.17至-0.46;P<0.001)。
临床怎么用
- 对急诊未需生命支持的高急性生理评分脓毒症患者,可考虑首选病房收治以缩短住院时间并改善生存。
- 对急性呼吸衰竭患者,尤其是老年、高急性生理评分和合并症较多者,ICU分诊可能改善生存。
局限性
- 回顾性设计可能残留混杂。
- 呼吸衰竭住院时间敏感性分析结果不一致,提示结论稳健性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Many decisions to admit patients to the ICU are not grounded in evidence regarding who benefits from such triage, straining ICU capacity and limiting its cost-effectiveness. Objectives: To measure the benefits of ICU admission for patients with sepsis or acute respiratory failure. Methods: At 27 United States hospitals across two health systems from 2013 to 2018, we performed a retrospective cohort study using two-stage instrumental variable quantile regression with a strong instrument (hospital capacity strain) governing ICU versus ward admission among high-acuity patients (i.e., laboratory-based acute physiology score v2 ⩾ 100) with sepsis and/or acute respiratory failure who did not require mechanical ventilation or vasopressors in the emergency department. Measurements and Main Results: Among patients with sepsis (n = 90,150), admission to the ICU was associated with a 1.32-day longer hospital length of stay (95% confidence interval [CI], 1.01-1.63; P < 0.001) (when treating deaths as equivalent to long lengths of stay) and higher in-hospital mortality (odds ratio, 1.48; 95% CI, 1.13-1.88; P = 0.004). Among patients with respiratory failure (n = 45,339), admission to the ICU was associated with a 0.82-day shorter hospital length of stay (95% CI, -1.17 to -0.46; P < 0.001) and reduced in-hospital mortality (odds ratio, 0.75; 95% CI, 0.57-0.96; P = 0.04). In sensitivity analyses of length of stay, excluding, ignoring, or censoring death, results were similar in sepsis but not in respiratory failure. In subgroup analyses, harms of ICU admission for patients with sepsis were concentrated among older patients and those with fewer comorbidities, and the benefits of ICU admission for patients with respiratory failure were concentrated among older patients, highest-acuity patients, and those with more comorbidities. Conclusions: Among high-acuity patients with sepsis who did not require life support in the emergency department, initial admission to the ward, compared with the ICU, was associated with shorter length of stay and improved survival, whereas among patients with acute respiratory failure, triage to the ICU compared with the ward was associated with improved survival.
引用
- Anesi GL, Liu VX, Chowdhury M, et al. Association of ICU Admission and Outcomes in Sepsis and Acute Respiratory Failure. Am J Respir Crit Care Med. 2022. PMID: 34818130. doi:10.1164/rccm.202106-1350OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。